Curiox Biosystems

IPO

Curiox Biosystems is a biotech company in Singapore, Singapore, founded in 2008. It has raised $33.2M across 3 rounds, most recently a $15.0M Series C in March 2022.

Centrifuge-free cell sample preparation for every scientist

Headquarters
Singapore
Employees
51–200
Founded
2008
Business Model
B2B
Website
curiox.com
Total Funding
$33.2M
Last Round
$15.0M Series CMar 2022
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Curiox Biosystems is a Singapore-headquartered biotechnology company founded in 2008 that is revolutionizing suspension cell sample preparation through its proprietary centrifuge-free technology platforms. The company's Laminar Wash technology eliminates traditional centrifugation steps that can disrupt cell integrity, improving sample viability and reproducibility in research and clinical diagnostics workflows. Its C-Free platform and Pluto automation systems deliver customizable, hands-free solutions for cell staining, antibody cocktailing, and centrifuge-free washing, and are validated at leading institutions including Stanford HIMC, Dana-Farber Cancer Institute, and AbbVie. In 2023, Curiox went public on the KOSDAQ exchange in South Korea, marking a significant milestone in its growth as a global life sciences automation company with offices in Singapore, Woburn (Massachusetts), and South Korea.

Summary

It lists 51–200 employees. It has raised $33.2M in total across 3 rounds, most recently a $15.0M Series C round in Mar 2022. Investors include Luha Private Equity, KB Investment and Quad Partners.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOAug 2023

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Curiox Biosystems on Indexed.vc
<a href="https://indexed.vc/companies/curiox-biosystems"><img src="https://indexed.vc/api/badge/company/curiox-biosystems" alt="Curiox Biosystems on Indexed.vc" width="260" height="76" /></a>